Schneider E, Lawson P A, Ralph R K
Department of Cellular and Molecular Biology, University of Auckland, New Zealand.
Biochem Pharmacol. 1989 Jan 15;38(2):263-9. doi: 10.1016/0006-2952(89)90036-1.
Stimulation of cleavable complex formation by 4'-(9-acridinylamino)methanesulfon-m-anisidide (mAMSA) and related anticancer drugs is an important initial event in drug action which correlates with cytotoxicity. However, it was recently suggested that factors in addition to cleavable complex formation are needed to express lethality. Therefore we investigated the effects of inhibitors of DNA replication and RNA and protein synthesis on mAMSA-induced cell killing in the K21 subline of the P815 murine mastocytoma cell line. This showed that RNA and protein synthesis, but not DNA replication, was necessary for maximal mAMSA cytotoxicity. Moreover, inhibition of RNA synthesis with cordycepin or protein synthesis with cycloheximide protected cells from the cytotoxic action of mAMSA without reducing DNA breakage or cleavable complex formation and there was no decrease in DNA topoisomerase II activity in nuclear extracts from cells treated with cordycepin or cycloheximide. We conclude that cleavable complex formation is independent of RNA and/or protein synthesis and we propose that the subsequent conversion into a lethal event requires an additional labile protein factor.
4'-(9-吖啶基氨基)甲磺基间茴香胺(mAMSA)及相关抗癌药物对可切割复合物形成的刺激作用是药物作用中的一个重要初始事件,这与细胞毒性相关。然而,最近有人提出,除了可切割复合物形成之外,还需要其他因素来表达致死性。因此,我们研究了DNA复制、RNA和蛋白质合成抑制剂对P815小鼠肥大细胞瘤细胞系K21亚系中mAMSA诱导的细胞杀伤作用的影响。结果表明,对于最大程度的mAMSA细胞毒性而言,RNA和蛋白质合成是必需的,但DNA复制并非必需。此外,用虫草素抑制RNA合成或用环己酰亚胺抑制蛋白质合成可保护细胞免受mAMSA的细胞毒性作用,而不会减少DNA断裂或可切割复合物的形成,并且用虫草素或环己酰亚胺处理的细胞的核提取物中的DNA拓扑异构酶II活性没有降低。我们得出结论,可切割复合物的形成独立于RNA和/或蛋白质合成,并且我们提出随后转化为致死事件需要一种额外的不稳定蛋白质因子。